These novel findings within our patients and the animal model strongly suggest that this retinovascular complication should be considered within the clinical spectrum of KCNJ13-related retinal dystrophy (rather than as an incidental and independent finding) and perhaps dependent on the specific nature and position of the mutation and its impact on protein function. This evidence concerns the gene KCNJ13 and Retinal dystrophy.